Form 4: IMMUNIC CFO Glenn Whaley Boosts Stake with Significant Stock Purchases

IMMUNIC, INC.'s Chief Financial Officer, Glenn Whaley, has significantly increased his direct beneficial ownership of common stock through two recent acquisitions, including an Employee Stock Purchase Plan transaction and an open market purchase.

Summary

• Glenn Whaley, Chief Financial Officer of IMMUNIC, INC. (IMUX), acquired a total of 70,000 shares of common stock through two separate transactions.
• On May 30, 2025, Mr. Whaley acquired 25,000 shares of common stock through the company's Employee Stock Purchase Plan (ESPP) at a price of $0.56 per share, which is 85% of the closing price on that date.
• On June 3, 2025, an additional 45,000 shares were purchased in the open market at a weighted average price of $0.7128 per share, with transaction prices ranging from $0.7127 to $0.7134.
• Following these acquisitions, Mr. Whaley's direct beneficial ownership of IMMUNIC common stock increased from 50,510 shares to 95,510 shares.

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to significant insider buying by the Chief Financial Officer, indicating strong management confidence in the company's future performance and valuation.

Positives

• Chief Financial Officer Glenn Whaley increased his direct beneficial ownership by 70,000 shares, signaling confidence in the company's future prospects.
• The acquisition of shares through the Employee Stock Purchase Plan (ESPP) at a discounted price of $0.56 per share indicates participation in employee benefit programs and a favorable valuation for employees.
• The open market purchase of 45,000 shares at an average price of $0.7128 further demonstrates management's belief in the company's current valuation and potential upside.

Future Outlook

NA

Industry Context

This Form 4 filing details an insider transaction, specifically the acquisition of common stock by a key executive. While not directly indicative of broader industry trends, insider buying can reflect management's confidence in the company's specific position within its sector.

Related Party Transactions

• Acquisition of 25,000 shares through the Issuer's Employee Stock Purchase Plan (ESPP) at a discounted price of $0.56 per share, which is a standard employee benefit program.

Stakeholder Impact

• Shareholders: May view the insider purchases as a strong positive signal of management confidence, potentially influencing investor sentiment and stock price.
• Employees: The CFO's participation in the ESPP highlights the availability and utilization of employee stock ownership programs within the company.

Key Dates

Recommendation

Keywords

IMMUNIC, IMUX, Glenn Whaley, CFO, insider trading, stock purchase, Form 4, beneficial ownership, employee stock purchase plan, ESPP